Integra LifeSciences Holdings (IART) Stock Price

IARTStock

$13.21−9.58%52W

Market Cap$1.03B

P/E—

PEG Ratio0.67

Div yield—

Beta1.28

IART Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)9.53%

Price vs S&P 500 (4W)-13.94%

PEG Ratio0.67

VGM Score44.06

P/CF (Annual)20.39x

Book Value / Share (Quarterly)$13.41

P/TBV (Annual)5.18x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)1.63%

Cash Flow / Share (Quarterly)$0.15

Price vs S&P 500 (YTD)-5.57%

Gross Margin (TTM)57.24%

Net Profit Margin (TTM)-0.44%

EPS (TTM)$-0.10

10-Day Avg Trading Volume1.23M

EPS Excl Extra (TTM)$-0.10

Revenue Growth (5Y)3.57%

EPS (Annual)$-6.74

ROI (Annual)-17.81%

Gross Margin (Annual)56.62%

Net Profit Margin (5Y Avg)-1.01%

Cash / Share (Quarterly)$3.52

Revenue Growth QoQ (YoY)0.76%

ROA (Last FY)-14.34%

Revenue Growth TTM (YoY)1.60%

EBITD / Share (TTM)$1.04

ROE (5Y Avg)-5.13%

Operating Margin (TTM)3.96%

Cash Flow / Share (Annual)$-0.58

P/B Ratio0.98x

P/B Ratio (Quarterly)1.34x

Net Income / Employee (Annual)$-116,700

EV / Revenue (TTM)1.63x

Net Interest Coverage (TTM)-7.31x

ROA (TTM)-0.20%

EV / EBITDA (TTM)33.47x

EPS Incl Extra (Annual)$-6.74

Current Ratio (Annual)2.54x

Quick Ratio (Quarterly)1.80x

3-Month Avg Trading Volume0.93M

52-Week Price Return-9.58%

EV / Free Cash Flow (Annual)16.19x

Revenue / Employee (TTM)$372,200

Tangible BV / Share (Quarterly)$4.33

P/S Ratio (Annual)0.63x

Asset Turnover (Annual)0.45x

52-Week High$20.49

Operating Margin (5Y Avg)1.78%

EPS Excl Extra (Annual)$-6.74

CapEx CAGR (5Y)8.40%

Tangible BV CAGR (5Y)-2.59%

26-Week Price Return19.44%

Quick Ratio (Annual)1.25x

13-Week Price Return-31.38%

Total Debt / Equity (Annual)1.78x

Current Ratio (Quarterly)3.60x

Enterprise Value$2.69B

Revenue / Share Growth (5Y)5.78%

Asset Turnover (TTM)0.46x

Book Value / Share Growth (5Y)-5.70%

Revenue / Employee (Annual)$369,400

Inventory Turnover (Annual)1.54x

Pretax Margin (Annual)-34.46%

Cash / Share (Annual)$3.39

3-Month Return Std Dev66.92%

Gross Margin (5Y Avg)61.07%

Net Income / Employee (TTM)$-1,600

EBITDA CAGR (5Y)-17.88%

EBITDA Interim CAGR (5Y)-16.23%

ROE (Last FY)-49.50%

Net Interest Coverage (Annual)1.00x

EPS Basic Excl Extra (Annual)$-6.74

P/FCF (TTM)28.35x

Receivables Turnover (TTM)5.97x

EV / Free Cash Flow (TTM)231.49x

Total Debt / Equity (Quarterly)1.79x

EPS Incl Extra (TTM)$-0.10

Receivables Turnover (Annual)5.93x

ROI (TTM)-0.25%

P/S Ratio (TTM)0.62x

Pretax Margin (5Y Avg)-0.54%

Revenue / Share (Annual)$21.33

Tangible BV / Share (Annual)$4.38

Forward P/E6.25x

Free OCF CAGR (5Y)-31.13%

Price vs S&P 500 (52W)-25.11%

Year-to-Date Return6.36%

5-Day Price Return-5.51%

EPS Normalized (Annual)$-6.74

ROA (5Y Avg)-0.72%

Net Profit Margin (Annual)-31.58%

Month-to-Date Return-18.86%

Cash Flow / Share (TTM)$2.73

EBITD / Share (Annual)$-6.26

Operating Margin (Annual)-30.25%

LT Debt / Equity (Annual)1.66x

P/CF (TTM)12.04x

ROI (5Y Avg)-1.01%

LT Debt / Equity (Quarterly)1.75x

EPS Basic Excl Extra (TTM)$-0.10

P/TBV (Quarterly)5.05x

P/B Ratio (Annual)0.93x

Inventory Turnover (TTM)1.47x

Pretax Margin (TTM)-0.01%

Book Value / Share (Annual)$13.40

Price vs S&P 500 (13W)-34.06%

Beta1.28x

P/FCF (Annual)68.44x

Revenue / Share (TTM)$21.08

ROE (TTM)-0.70%

52-Week Low$8.70

vGradeB

gGradeF

mGradeC

vgmGradeC

IART Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	$0.48	$0.56	+16.50%(+$0.08)
Q1 2026	May 5, 2026	$0.40	$0.54	+33.36%(+$0.14)
Q4 2025	Feb 26, 2026	$0.80	$0.83	+3.73%(+$0.03)
Q3 2025	Oct 30, 2025	$0.43	$0.54	+24.30%(+$0.11)
Q2 2025	Jul 31, 2025	$0.43	$0.45	+4.38%(+$0.02)

IART Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.73

3.63

3.56

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Integra LifeSciences Holdings

Integra Lifesciences Holdings Corp is a New Jersey-based medical devices company specializing in regenerative therapy, extremity orthopedics, and neurosurgical solutions. The company operates through two main segments—Codman Specialty Surgical, which generates the majority of revenue, and Tissue Technologies—with a global presence spanning North America, Europe, and Asia Pacific, supported by substantial U.S. market sales.

IART Next Earnings Report

Report dateOct 21, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$0.56

Revenue estimate$412.10M

Also reporting on Oct 21, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for October 2026

Companies in Related Industries

LYNXLyntris Inc.Defense Systems & Equipment
ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment
KODKEASTMAN KODAK COMPANYPhotographic Equipment & Supplies
INMDInMode Ltd. Ordinary SharesElectromedical Equipment
TRNSTranscat IncInstruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

3.6

Buy

Consensus rating

52-Week Range

Low$8.70

High$20.49